Tadashi Terasaka

436 total citations
20 papers, 350 citations indexed

About

Tadashi Terasaka is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Tadashi Terasaka has authored 20 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Physiology and 4 papers in Oncology. Recurrent topics in Tadashi Terasaka's work include Adenosine and Purinergic Signaling (10 papers), Fibroblast Growth Factor Research (5 papers) and Biochemical and Molecular Research (3 papers). Tadashi Terasaka is often cited by papers focused on Adenosine and Purinergic Signaling (10 papers), Fibroblast Growth Factor Research (5 papers) and Biochemical and Molecular Research (3 papers). Tadashi Terasaka collaborates with scholars based in Japan. Tadashi Terasaka's co-authors include Isao Nakanishi, Takayoshi Kinoshita, Masako Kuno, Nobuo Seki, Katsuya Nakamura, Takashi Fujii, Minoru Kameda, Masaaki Hirano, Susumu Tsujimoto and Kenji Kano and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Tadashi Terasaka

19 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tadashi Terasaka Japan	10	220	108	76	34	31	20	350
Pauline Bourbon United States	9	137 0.6×	44 0.4×	97 1.3×	15 0.4×	22 0.7×	12	339
Janak Padia United States	10	223 1.0×	52 0.5×	172 2.3×	48 1.4×	11 0.4×	18	445
Jens Hausmann Netherlands	9	357 1.6×	39 0.4×	49 0.6×	35 1.0×	17 0.5×	16	423
Grzegorz Stasiłojć Poland	12	201 0.9×	95 0.9×	88 1.2×	78 2.3×	8 0.3×	33	497
Jeffrey Tredup United States	10	191 0.9×	15 0.1×	109 1.4×	71 2.1×	26 0.8×	17	360
Sadao Hikishima Japan	11	380 1.7×	52 0.5×	138 1.8×	28 0.8×	4 0.1×	26	484
Jamal El Bakali France	12	157 0.7×	12 0.1×	183 2.4×	25 0.7×	30 1.0×	24	405
Nikolaos Lougiakis Greece	10	164 0.7×	23 0.2×	142 1.9×	30 0.9×	16 0.5×	37	447
Federico Medda United States	14	242 1.1×	26 0.2×	300 3.9×	50 1.5×	43 1.4×	21	613
Jiacheng Wei China	8	269 1.2×	30 0.3×	18 0.2×	60 1.8×	88 2.8×	10	364

Countries citing papers authored by Tadashi Terasaka

Since Specialization

Citations

This map shows the geographic impact of Tadashi Terasaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadashi Terasaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadashi Terasaka more than expected).

Fields of papers citing papers by Tadashi Terasaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadashi Terasaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadashi Terasaka. The network helps show where Tadashi Terasaka may publish in the future.

Co-authorship network of co-authors of Tadashi Terasaka

This figure shows the co-authorship network connecting the top 25 collaborators of Tadashi Terasaka. A scholar is included among the top collaborators of Tadashi Terasaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadashi Terasaka. Tadashi Terasaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kameda, Minoru, Yuichiro Kawamoto, Hiroyuki Moritomo, et al.. (2022). Discovery of ASP5878: Synthesis and structure–activity relationships of pyrimidine derivatives as pan-FGFRs inhibitors with improved metabolic stability and suppressed hERG channel inhibitory activity. Bioorganic & Medicinal Chemistry. 59. 116657–116657. 8 indexed citations

Kameda, Minoru, Yuichiro Kawamoto, Hiroyuki Moritomo, et al.. (2021). Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency. Bioorganic & Medicinal Chemistry. 33. 116019–116019. 9 indexed citations

Futami, T., Hidetsugu Okada, Rumi Kihara, et al.. (2016). ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 16(1). 68–75. 34 indexed citations

Suzuki, Tomoyuki, Ayako Nakayama, Tohru Ozawa, et al.. (2016). ASP5878, a selective FGFR inhibitor, to treat FGFR3‐dependent urothelial cancer with or without chemoresistance. Cancer Science. 108(2). 236–242. 22 indexed citations

Futami, T., Hidetsugu Okada, Rumi Kihara, et al.. (2015). Abstract A172: Preclinical antitumor activity of ASP5878, a novel inhibitor of FGFR1, 2, 3 and 4, in FGF19-expressing hepatocellular carcinoma. Molecular Cancer Therapeutics. 14(12_Supplement_2). A172–A172. 1 indexed citations

Kaneko, Naoki, Hiroaki Tanaka, Hiroko Yamamoto, et al.. (2015). Abstract B188: Preclinical antitumor activity of ASP8273, a mutant-selective irreversible EGFR inhibitor in an AXL-overexpressing NSCLC model. Molecular Cancer Therapeutics. 14(12_Supplement_2). B188–B188. 1 indexed citations

Kobayashi, Miki, Yoshiyuki Tenda, Susumu Tsujimoto, et al.. (2013). Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of “chemoattractant receptor homologous molecule expressed on Th2 cells” (CRTH2). European Journal of Pharmaceutical Sciences. 49(3). 434–440. 8 indexed citations

Ito, Shinji, Tadashi Terasaka, Hiroshi Nagata, et al.. (2011). Discovery of novel and potent CRTH2 antagonists. Bioorganic & Medicinal Chemistry Letters. 22(2). 1194–1197. 5 indexed citations

Terasaka, Tadashi, et al.. (2010). Evaluation of maskless electron beam direct writing with double character projection apertures. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 7637. 76370D–76370D.

10.

Kuno, Masako, Nobuo Seki, Susumu Tsujimoto, et al.. (2006). Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938. European Journal of Pharmacology. 534(1-3). 241–249. 39 indexed citations

11.

Terasaka, Tadashi. (2005). Non-nucleoside adenosine deaminase inhibitors: 2000 – 2004. Expert Opinion on Therapeutic Patents. 15(7). 817–828. 2 indexed citations

12.

Kinoshita, Takayoshi, Isao Nakanishi, Tadashi Terasaka, et al.. (2005). Structural Basis of Compound Recognition by Adenosine Deaminase. Biochemistry. 44(31). 10562–10569. 36 indexed citations

13.

Terasaka, Tadashi, Kiyoshi Tsuji, Takeshi Kato, et al.. (2005). Rational Design of Non-Nucleoside, Potent, and Orally Bioavailable Adenosine Deaminase Inhibitors: Predicting Enzyme Conformational Change and Metabolism. Journal of Medicinal Chemistry. 48(15). 4750–4753. 18 indexed citations

14.

Terasaka, Tadashi, et al.. (2004). Structure-Based Design, Synthesis, and Structure−Activity Relationship Studies of Novel Non-nucleoside Adenosine Deaminase Inhibitors. Journal of Medicinal Chemistry. 47(15). 3730–3743. 36 indexed citations

15.

Terasaka, Tadashi, et al.. (2004). A Highly Potent Non-Nucleoside Adenosine Deaminase Inhibitor: Efficient Drug Discovery by Intentional Lead Hybridization [J. Am. Chem. Soc. 2004, 126, 34−35].. Journal of the American Chemical Society. 126(21). 6833–6833. 2 indexed citations

16.

Terasaka, Tadashi, Hiroyuki Okumura, Kiyoshi Tsuji, et al.. (2004). Structure-Based Design and Synthesis of Non-Nucleoside, Potent, and Orally Bioavailable Adenosine Deaminase Inhibitors. Journal of Medicinal Chemistry. 47(11). 2728–2731. 20 indexed citations

17.

Terasaka, Tadashi, Isao Nakanishi, Katsuya Nakamura, et al.. (2003). Structure-Based de novo design of non-nucleoside adenosine deaminase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(6). 1115–1118. 15 indexed citations

18.

Terasaka, Tadashi, Takayoshi Kinoshita, Masako Kuno, & Isao Nakanishi. (2003). A Highly Potent Non-Nucleoside Adenosine Deaminase Inhibitor: Efficient Drug Discovery by Intentional Lead Hybridization. Journal of the American Chemical Society. 126(1). 34–35. 47 indexed citations

19.

Itoh, Shinobu, Masaki Ogino, Tadashi Terasaka, et al.. (1995). A Model Compound of the Novel Cofactor Tryptophan Tryptophylquinone of Bacterial Methylamine Dehydrogenases. Synthesis and Physicochemical Properties. Journal of the American Chemical Society. 117(5). 1485–1493. 44 indexed citations

20.

Itoh, Shinobu, et al.. (1992). Efficient NAD+-recycling system for ADH-catalysed oxidation in organic media. Journal of the Chemical Society Perkin Transactions 1. 3253–3253. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact